{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:50:56Z","timestamp":1764172256956,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001064","name":"Epilepsy Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001064","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Royal Melbourne Hospital Neuroscience Foundation"},{"DOI":"10.13039\/501100000407","name":"Epilepsy Action","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Health and Medical Research Council"},{"name":"Pharmaceutical Industry, viz. Sci-Gen"},{"name":"UCB Pharma"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.seizure.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T12:36:52Z","timestamp":1518871012000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications"],"prefix":"10.1016","volume":"56","author":[{"given":"Dana","family":"Jazayeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.E.","family":"Vajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"Drug Class Review: Antiepileptic Drugs for Indications Other Than Epilepsy: Final Report Update 2","author":"McDonagh","key":"10.1016\/j.seizure.2018.02.009_bib0005"},{"key":"10.1016\/j.seizure.2018.02.009_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09638230903469186","article-title":"Anticonvulsants in bipolar disorder","volume":"19","author":"Grunze","year":"2010","journal-title":"J Ment Health"},{"key":"10.1016\/j.seizure.2018.02.009_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2012.05.024","article-title":"Lamotrigine in epilepsy, pregnancy and psychiatry\u2013a drug for all seasons?","volume":"20","author":"Vajda","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2018.02.009_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","article-title":"Management of bipolar disorder during pregnancy and the postpartum period","volume":"161","author":"Yonkers","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.seizure.2018.02.009_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-5618.2006.00295.x","article-title":"Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers","volume":"8","author":"Gentile","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.seizure.2018.02.009_bib0030","first-page":"513160","article-title":"Multiple sclerosis and pregnancy: current considerations","volume":"2014","author":"Buraga","year":"2014","journal-title":"Sci World"},{"key":"10.1016\/j.seizure.2018.02.009_bib0035","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","article-title":"Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy","volume":"11","author":"Vajda","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2018.02.009_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2018.02.009_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"group Es: dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.02.009_bib0050","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jocn.2010.05.008","article-title":"Review: the Australian pregnancy register of anti-epileptic drugs: 10 years of progress","volume":"17","author":"Vajda","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2018.02.009_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/tcrm.1.1.21.53605","article-title":"Should valproate be taken during pregnancy","volume":"1","author":"Eadie","year":"2005","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.seizure.2018.02.009_bib0060","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2018.02.009_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2015.02.004","article-title":"Improving the prescription of folate to women receiving antiepileptic drugs","volume":"112","author":"Sharma","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.02.009_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/bdra.23110","article-title":"Descriptive epidemiology of cleft lip and cleft palate in Western Australia","volume":"97","author":"Bell","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.seizure.2018.02.009_bib0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1479-828X.2011.01359.x","article-title":"The prescribing of antiepileptic drugs for pregnant Australian women","volume":"52","author":"Vajda","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.seizure.2018.02.009_bib0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdra.23147","article-title":"Valproate prescriptions for nonepilepsy disorders in reproductive-age women","volume":"97","author":"Adedinsewo","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.seizure.2018.02.009_bib0085","doi-asserted-by":"crossref","first-page":"g5159","DOI":"10.1136\/bmj.g5159","article-title":"Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study","volume":"349","author":"Bech","year":"2014","journal-title":"BMJ"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:50:01Z","timestamp":1761011401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":17,"alternative-id":["S1059131118300104"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.02.009","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}